Business Description
Kontafarma China Holdings Ltd
ISIN : KYG8918D1088
Total Employee Number:
616Compare
Compare
Traded in other countries / regions
01312.Hong Kong IPO Date
2012-01-18Description
Kontafarma China Holdings Ltd and its subsidiaries are principally engaged in the pharmaceutical and fitness business. The Group manufactures and sells prescription drugs, including chemical drugs, traditional Chinese medicine prescriptions, active pharmaceutical ingredients, and API intermediates in China, and operates fitness centres, provides fitness and health consultation services, and operates a franchise business for royalty fee income. Its segments are the pharmaceutical business, which generates maximum revenue, and the fitness business. The Group operates in Mainland China, Singapore, Taiwan, and other regions, with maximum revenue from Mainland China.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.07 | |||||
Beneish M-Score | -5.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.8 | |||||
3-Year EPS without NRI Growth Rate | -56.4 | |||||
3-Year Book Growth Rate | -20.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.85 | |||||
9-Day RSI | 60.13 | |||||
14-Day RSI | 58.16 | |||||
3-1 Month Momentum % | 3.33 | |||||
12-1 Month Momentum % | 6.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 80.54 | |||||
Days Sales Outstanding | 47.32 | |||||
Days Payable | 6.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.15 | |||||
Operating Margin % | -25.41 | |||||
Net Margin % | -46.77 | |||||
EBITDA Margin % | -48.54 | |||||
FCF Margin % | 5.81 | |||||
OCF Margin % | 8.38 | |||||
ROE % | -57.9 | |||||
ROA % | -33.73 | |||||
ROIC % | -20.45 | |||||
3-Year ROIIC % | 19.06 | |||||
ROC (Joel Greenblatt) % | -114.23 | |||||
ROCE % | -53.6 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.22 | |||||
PB Ratio | 0.33 | |||||
Price-to-Tangible-Book | 0.83 | |||||
Price-to-Free-Cash-Flow | 3.68 | |||||
Price-to-Operating-Cash-Flow | 2.37 | |||||
EV-to-EBIT | -0.55 | |||||
EV-to-EBITDA | -0.55 | |||||
EV-to-Revenue | 0.27 | |||||
EV-to-FCF | 4.61 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 0.47 | |||||
Price-to-Median-PS-Value | 0.47 | |||||
Earnings Yield (Greenblatt) % | -181.82 | |||||
FCF Yield % | 28.82 | |||||
Forward Rate of Return (Yacktman) % | -48.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kontafarma China Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 914.709 | ||
| EPS (TTM) (HK$) | -0.077 | ||
| Beta | 0.4182 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.15 | ||
| Volatility % | 33.8 | ||
| 14-Day RSI | 58.16 | ||
| 14-Day ATR (HK$) | 0.002649 | ||
| 20-Day SMA (HK$) | 0.03005 | ||
| 12-1 Month Momentum % | 6.9 | ||
| 52-Week Range (HK$) | 0.02 - 0.048 | ||
| Shares Outstanding (Mil) | 5,588.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kontafarma China Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kontafarma China Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 5:1 Stock Split | 2015-01-20 | 0.62 (-0.32%) |
Show
Entries
Kontafarma China Holdings Ltd Frequently Asked Questions
What is Kontafarma China Holdings Ltd(HKSE:01312)'s stock price today?
The current price of HKSE:01312 is HK$0.03. The 52 week high of HKSE:01312 is HK$0.05 and 52 week low is HK$0.02.
When is next earnings date of Kontafarma China Holdings Ltd(HKSE:01312)?
The next earnings date of Kontafarma China Holdings Ltd(HKSE:01312) is .
Does Kontafarma China Holdings Ltd(HKSE:01312) pay dividends? If so, how much?
Kontafarma China Holdings Ltd(HKSE:01312) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kontafarma China Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers